mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.2 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.2 |